Close Menu
Advertisement
Subscribe
[the_ad id="32629"]
Acute Lymphoblastic Leukemia

Biomarkers for PD-1 checkpoint inhibition

Editor By No Comments1 Min Read

Suzanne L. Topalian of Johns Hopkins University School of Medicine Sidney Kimmel Comprehensive Cancer Center discusses Biomarkers for PD-1 checkpoint inhibition at the Kidney Cancer meeting in Chicago

Share.

Related Posts